2026 NPPES data Ophthalmology Physician NPI 1215302146 M.D.
Verify on CMS →

AMER ALWREIKAT, M.D.

Ophthalmology Physician in BURLINGTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 904 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4157/100
▲ 8 pts above national avg 83.1 · [object Object]
What the federal data reveals: AMER ALWREIKAT, M.D. is a Ophthalmology Physician ([object Object]) practicing in BURLINGTON, Massachusetts with a Medicare Part D prescribing footprint of 5K claims across 904 beneficiaries — 27% brand-name prescribing . Their CMS MIPS Final Score of 91.4157/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: AMER ALWREIKAT, M.D. reported a CMS MIPS final score of 91.4157 out of 100, above the 83.1 national average, and filed 4,657 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

AMER ALWREIKAT, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

AMER ALWREIKAT, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 12/03/2015

NPI 1215302146

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

4,657 228% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

91.4157/100 8.315700000000007% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Ophthalmology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Ophthalmology Physician share within Massachusetts

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Massachusetts

Medicare quality performance — MIPS

AMER ALWREIKAT, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
91.4157/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 91.4157/100 vs national avg 83.1

0%100%National avg83%91.4%
MIPS final score (Ophthalmology Physician) — 91.4157/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMER ALWREIKAT, M.D. is a Ophthalmology Physician provider practicing in BURLINGTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1215302146. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AMER ALWREIKAT, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 41 MALL RD, BURLINGTON, MA, 01805, with a listed phone of (978) 558-4440. NPI 1215302146 was issued on 12/03/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALWREIKAT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,657 prescription claims written by this provider, covering 904 Medicare beneficiaries and totaling roughly $265K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4157/100 for the 2023 performance year (Quality 76.877), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

41 MALL RD
BURLINGTON, MA 01805

Provider Details

NPI 1215302146
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 12/03/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.4157
Final Score
Avg: 83.1
76.877
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where AMER ALWREIKAT, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LAHEY CLINIC INC
PEABODY, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to AMER ALWREIKAT, M.D.. To verify AMER ALWREIKAT, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

AMER ALWREIKAT, M.D. — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 4,657 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,657
Total Claims
$265K
Total Drug Cost
904
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,878
Total Day Supply
218,511
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$176K
Generic Drug Cost
$89K

Patient Demographics

Average Patient Age
77.8 years
Avg HCC Risk Score
1.15
Gender Split
55% female / 45% male
Age Distribution
<65: 31, 65-74: 285, 75-84: 406, 85+: 182

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
1,334
Prednisolone Acetate
625
Ketorolac Tromethamine
583
Ofloxacin
495
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
452
Brimonidine Tartrate
292
Timolol Maleate
207
Dorzolamide Hcl
160
Lumigan
Bimatoprost
56
Levobunolol Hcl
53

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How AMER ALWREIKAT, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

AMER ALWREIKAT, M.D.'s 4,657 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as ALWREIKAT.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMER ALWREIKAT, M.D.'s specialty?
AMER ALWREIKAT, M.D. specializes in Ophthalmology Physician and practices in BURLINGTON, Massachusetts. Credentials: M.D..
How much does AMER ALWREIKAT, M.D. prescribe under Medicare Part D?
In 2023, AMER ALWREIKAT, M.D. wrote 4,657 Medicare Part D claims totaling $265K in drug costs for 904 beneficiaries.
What is AMER ALWREIKAT, M.D.'s Medicare quality score?
AMER ALWREIKAT, M.D. has a CMS MIPS Final Score of 91.4157/100 (Quality: 76.877). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AMER ALWREIKAT, M.D. located?
AMER ALWREIKAT, M.D. is located at 41 MALL RD, BURLINGTON, MA, 01805. Phone: (978) 558-4440.
What is AMER ALWREIKAT, M.D.'s NPI number?
AMER ALWREIKAT, M.D.'s National Provider Identifier (NPI) is 1215302146, issued on 12/03/2015.
Does AMER ALWREIKAT, M.D. prescribe more brand-name or generic drugs?
AMER ALWREIKAT, M.D.'s prescribing is 27% brand-name and 73% generic drugs by claim count, with $176K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does AMER ALWREIKAT, M.D. prescribe most often?
Based on 2023 Medicare Part D data, AMER ALWREIKAT, M.D.'s most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMER ALWREIKAT, M.D. accept Medicare?
AMER ALWREIKAT, M.D. appears in CMS Medicare data with 4,657 Part D claims and 904 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMER ALWREIKAT, M.D.'s credentials?
AMER ALWREIKAT, M.D.'s NPI is 1215302146 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology